Published in Blood Weekly, September 11th, 1995
The data were reported at the annual meeting of the International Society of Experimental Hematology in Dusseldorf, Germany.
"The results of these and earlier studies provide support for the use of Betafectin to restore white blood cell and platelet populations following cancer chemotherapy. These studies and additional data generated by our collaborators, are the foundation of the clinical program...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.